KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Debt to Equity: 2018-2025

Historic Debt to Equity for Esperion Therapeutics (ESPR) over the last 1 years, with Sep 2025 value amounting to -$0.34.

  • Esperion Therapeutics' Debt to Equity was N/A to -$0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.34, marking a year-over-year change of. This contributed to the annual value of -$0.36 for FY2024, which is N/A change from last year.
  • As of Q3 2025, Esperion Therapeutics' Debt to Equity stood at -$0.34, which was up 0.54% from -$0.34 recorded in Q2 2025.
  • Esperion Therapeutics' Debt to Equity's 5-year high stood at -$0.33 during Q1 2025, with a 5-year trough of -$0.36 in Q4 2024.
  • Moreover, its 2-year median value for Debt to Equity was -$0.34 (2025), whereas its average is -$0.34.